Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(6):410-411; doi:10.1093/jnci/97.6.410
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Correction (v97,p559)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zielinski, S. L.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Clinical Trials Registration Efforts Gain Some Ground

Sarah L. Zielinski

The first 150 words of the full text of this article appear below.

Hundreds of public and private clinical trials registries have been created in the last few decades, and the worth of such efforts has been discussed in meetings and in the pages of scientific journals. But clinical trials registration received newfound attention about a year ago when several pharmaceutical companies were accused of suppressing clinical trial data that raised questions about the safety of some popular antidepressants when used in children.

Registration is now viewed as the best way to prevent this from happening again. But with many different organizations—including medical journals, the U.S. Congress, and the World Health Organization—developing their own plans for how and when registration should happen, it is not clear whether or exactly how the goal of greater transparency in the clinical trials system will be achieved.

The allegations of suppressed data make headlines, but the larger implications of a suppressed or unregistered trial are often reported . . . [Full Text of this Article]

Early Registries

Pharmaceutical Support

Worldwide Standardization?

Clinical Trials Registration Web Sites


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Clinical Trials Registration Efforts Gain Some Ground
Richard E. Manrow
J Natl Cancer Inst 2005 97: 936. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
R. E. Manrow
Re: Clinical Trials Registration Efforts Gain Some Ground
J Natl Cancer Inst, June 15, 2005; 97(12): 936 - 936.
[Full Text] [PDF]